Active Clinical Trials

Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma

By April 24, 2017 No Comments


Malignant Pleural Mesothelioma

Estimated Enrollment: 60

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: No masking|Primary Purpose: Treatment

Study ID Numbers: ADU-CL-02

Study First Received: August 23, 2012

Last Updated: January 25, 2017

Estimated Primary Completion Date: June 2017


Primary Outcome Measures:

Number of subjects reporting adverse events|Induction of immune response to mesothelin by enzyme-linked immunosorbent spot (ELISPOT) assay|Objective tumor response|Time to progression|Serum mesothelin as correlate of therapeutic response

Sponsors and Collaborators:

Aduro Biotech, Inc.

Website Link:

Leave a Reply

Call Now ButtonCall Now